Deucravacitinib 6mg Tablet – Imported | Long Product Description

Product Overview

Deucravacitinib 6mg Tablet – Imported is a prescription medicine containing deucravacitinib, a selective tyrosine kinase 2 (TYK2) inhibitor. It helps regulate specific immune-system signalling pathways involved in inflammation.

Deucravacitinib is primarily used to treat adults with moderate to severe plaque psoriasis who are candidates for systemic treatment or phototherapy. In some jurisdictions, it is also approved for active psoriatic arthritis in adults. The approved uses depend on local prescribing guidelines and product authorisation.

This imported product is listed with Lucius Pharmaceuticals as the manufacturer and a pack size of 30 tablets. It should be used under the supervision of a qualified healthcare professional experienced in treating inflammatory and immune-mediated conditions.

Key Product Information

• Product Name: Deucravacitinib 6mg Tablet
• Generic Name: Deucravacitinib
• Strength: 6mg
• Dosage Form: Tablet
• Manufacturer: Lucius Pharmaceuticals
• Pack Size: 30 Tablets
• Product Type: Imported Medicine
• Drug Class: TYK2 Inhibitor
• Therapeutic Category: Immunomodulatory Medicine
• Primary Use: Treatment of plaque psoriasis in eligible adults
• Availability: Contact MedicineWalyDost.com to confirm current stock and prescription requirements.

Uses of Deucravacitinib 6mg Tablet

1. Plaque Psoriasis

Plaque psoriasis is a chronic inflammatory skin condition that causes raised, red or discoloured patches covered with scales. These patches can cause itching, discomfort, dryness, and cracking.

Deucravacitinib helps regulate immune-system activity associated with psoriasis and may improve skin lesions in eligible adults with moderate to severe disease.

2. Management of Psoriasis Symptoms

By reducing specific inflammatory signals, deucravacitinib may help improve the appearance and severity of psoriasis plaques over time. The extent of improvement varies between individuals.

3. Active Psoriatic Arthritis

In certain jurisdictions where this indication is approved, deucravacitinib may also be prescribed for active psoriatic arthritis in adults. This inflammatory condition can cause joint pain, stiffness, swelling, and inflammation in people with psoriasis.

Important: Treatment suitability depends on the patient’s diagnosis, local product approval, medical history, and the prescribing specialist’s assessment.

How Does Deucravacitinib Work?

Deucravacitinib selectively inhibits TYK2, an enzyme involved in signalling pathways associated with inflammatory cytokines, including interleukin-23 and type I interferons.

These signalling pathways play an important role in the immune response associated with plaque psoriasis. By reducing TYK2-mediated signalling, deucravacitinib helps regulate inflammation that contributes to psoriasis symptoms.

Unlike some other immune-modifying medicines, deucravacitinib targets TYK2 through an allosteric mechanism. Its effectiveness and tolerability depend on individual patient factors.

Dosage and How to Take Deucravacitinib 6mg

Deucravacitinib should be taken exactly as prescribed by your healthcare professional.

• Follow the prescribed dose and schedule.
• The standard approved adult dose for plaque psoriasis is generally 6mg once daily, subject to the applicable product information and your doctor’s advice.
• The tablet may be taken with or without food.
• Swallow the tablet whole. Do not crush, cut, or chew it.
• Do not change the dose or stop treatment without consulting your doctor.
• If you miss a dose, follow the patient leaflet or ask your pharmacist for guidance.
• Attend scheduled follow-up appointments and recommended tests.

The 6mg strength is the standard approved dose for plaque psoriasis in the relevant prescribing information, but the medicine is not suitable for everyone. Your doctor will determine whether treatment is appropriate for you.

Possible Side Effects

Like other prescription medicines, Deucravacitinib 6mg Tablet can cause side effects. Not everyone experiences them.

Possible side effects include:

• Upper respiratory tract infections
• Common cold-like symptoms
• Headache
• Mouth ulcers
• Acne or skin-related symptoms
• Folliculitis, which is inflammation of hair follicles
• Nausea or other gastrointestinal symptoms
• Changes in muscle enzymes detected through blood tests

Serious Side Effects and Risks

Infections: Deucravacitinib may increase the risk of infections. Contact your healthcare professional if you develop fever, persistent cough, chills, or other signs of infection.

Tuberculosis: Patients should be evaluated for tuberculosis before treatment. Active tuberculosis must be treated before considering this medicine.

Allergic reactions: Seek immediate medical attention if you experience facial or throat swelling, difficulty breathing, or another severe allergic reaction.

Muscle problems: Unexplained muscle pain, tenderness, or weakness should be reported to your doctor, particularly if symptoms are severe.

Malignancy risk: Malignancies have been reported in clinical studies. Discuss your personal and family medical history with your specialist before starting treatment.

Seek urgent medical attention for severe or rapidly worsening symptoms.

Precautions and Warnings

Before taking Deucravacitinib 6mg Tablet, inform your healthcare professional about your medical history and current medicines.

Infection Screening

Your doctor may screen for tuberculosis and assess other infection risks before treatment. Patients with active, clinically important infections may need to delay treatment until the infection has resolved or been adequately treated.

Liver Conditions

Inform your doctor if you have liver disease. Deucravacitinib is generally not recommended in patients with severe hepatic impairment under the relevant prescribing information.

Vaccinations

Discuss your vaccination history with your doctor before starting treatment. Vaccinations should be reviewed according to current clinical guidance, and live vaccines should generally be avoided during treatment.

Pregnancy and Breastfeeding

If you are pregnant, planning a pregnancy, or breastfeeding, consult your healthcare professional before using deucravacitinib. Your doctor will assess the potential risks and benefits.

Previous or Recurrent Infections

Tell your doctor if you have a history of tuberculosis, recurrent infections, or another condition that may increase your risk of infection.

Regular Monitoring

Attend recommended follow-up appointments and complete any tests requested by your healthcare professional. Report new symptoms or unusual changes in your health promptly.

Drug Interactions

Before starting Deucravacitinib 6mg, provide your doctor or pharmacist with a complete list of prescription medicines, over-the-counter products, and supplements you take.

Your healthcare professional should review potential interactions and assess whether any other treatment could increase your risk of infection or adverse effects.

Do not start, stop, or combine immune-modifying medicines without professional guidance.

Who Should Use Deucravacitinib 6mg?

Deucravacitinib may be suitable for adults with moderate to severe plaque psoriasis who meet the relevant criteria for systemic treatment.

In jurisdictions where approved, it may also be considered for adults with active psoriatic arthritis.

It is not intended for self-medication. A qualified healthcare professional should assess the diagnosis, infection history, liver health, other medicines, and individual treatment needs before prescribing it.

Patients with active serious infections or a known allergy to the active ingredient or another component of the product may need to avoid treatment.

Storage Instructions

• Store the medicine according to the instructions on the original packaging.
• Protect the tablets from excessive heat and moisture.
• Keep the medicine in its original packaging when appropriate.
• Keep it out of the reach of children and pets.
• Do not use the medicine after its expiry date.
• Do not use the product if its packaging is damaged or appears tampered with.

Why Choose MedicineWalyDost.com?

MedicineWalyDost.com helps customers explore imported medicines and access useful product information before purchasing.

For Deucravacitinib 6mg Tablet, customers can contact the website to confirm current price, availability, manufacturer details, pack size, prescription requirements, and delivery options.

Before ordering, verify the product name, strength, packaging, and manufacturer. Prescription medicines should be purchased through an appropriately authorised pharmacy and used under medical supervision.

Frequently Asked Questions (FAQs)

1. What is Deucravacitinib 6mg Tablet used for?

Deucravacitinib is primarily used to treat moderate to severe plaque psoriasis in eligible adults. Other approved uses may apply in certain jurisdictions.

2. How does deucravacitinib work?

It selectively inhibits TYK2, an enzyme involved in immune signalling pathways that contribute to inflammation.

3. Who is the manufacturer of this product?

The manufacturer specified for this listing is Lucius Pharmaceuticals. Confirm the manufacturer against the original product packaging before purchase.

4. What is the pack size?

The product details provided specify a pack size of 30 tablets.

5. How should Deucravacitinib 6mg be taken?

The standard approved dose for plaque psoriasis is generally 6mg once daily. Follow your prescription and swallow the tablet whole without crushing, cutting, or chewing it.

6. What are the possible side effects?

Possible side effects include upper respiratory tract infections, headache, mouth ulcers, acne, and folliculitis. More serious risks include significant infections and allergic reactions.

7. Does deucravacitinib require medical monitoring?

Yes. Your healthcare professional should assess infection risks before treatment and monitor your health during therapy as clinically appropriate.

8. How can I confirm availability in Pakistan?

Contact MedicineWalyDost.com to confirm current availability, price, prescription requirements, and delivery details.

Contact MedicineWalyDost.com Today

Looking for Deucravacitinib 6mg Tablet – Imported? Contact MedicineWalyDost.com to confirm current price, availability, prescription requirements, and delivery options.

Use this medicine only as prescribed by a qualified healthcare professional.